L-glutaminase and L-asparaginase by extracorporeal route in acute lymphoblastic leukemia therapy.
Use of L-asparaginase by the extracorporeal route in the therapy of acute lymphoblastic leukemia (ALL) has been proposed. Results, however, are not so satisfactory as i.v. administration of this enzyme, because the levels of L-asparagine do not fall for a sufficient length of time due to the antagonistic action of the L-asparagine-synthetase. To avoid the L-asparagine rebound we have utilized, by extracorporeal route, L-glutaminase together with L-asparaginase, in order to reduce L-asparagine and L-glutamine levels. We have therefore performed a series of experiments in vitro and in vivo either using L-asparaginase alone or together with L-glutaminase. Results show that, contrary to what happens when L-asparaginase is used alone, L-asparagine levels decrease and remain low even after 24 hours from the treatment, when L-glutaminase is added to the system. Thus a lowering of L-glutamine levels, which seems to play an important role in the therapy of ALL, is obtained.
D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005112:Extracorporeal Circulation; D005972:Glutaminase / Q000008:administration & dosage*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D051381:Rats
D001215:Asparaginase; D005972:Glutaminase